Florida 2019 Regular Session Status: Passed House

HB 59 — Prescription Drug Donation Repository Program

Last action — Died in Health Policy

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2019 Regular Session. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Bill Text

What changed in the latest version

373 added · 581 removed

373 line(s) added, 581 removed.

→
Previous
Latest
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 A bill to be entitled An act relating to the Prescription Drug Donation Repository Program;
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/CS/HB 59 2019 A bill to be entitled An act relating to the Prescription Drug Donation Repository Program;
authorizing the department to contract with a third-party vendor to administer the program;
specifying entities that may participate as repositories;
specifying entities that are eligible donors;
requiring a repository to notify the department of its intent to participate in the program;
providing notification requirements;
providing a procedure for a repository to withdraw from participation in the program;
requiring the department to adopt rules regarding the disposition of prescription drugs and supplies of a withdrawing repository;
specifying entities that may donate prescription drugs or supplies under the program;
providing that certain prescription drugs eligible for return to stock must be credited to Medicaid and may not be donated under the program;
providing inspection, inventory, and storage requirements for repositories;
prohibiting the donation of certain drugs pursuant to federal restrictions;
clarifying that a repository is not required to accept donations of prescription drugs or supplies;
providing inspection, inventory, and storage requirements for centralized and local repositories;
requiring a local repository to notify the centralized repository within a specified timeframe after receiving a donation of prescription drugs or supplies;
requiring a repository to submit its inventory records to the department monthly;
authorizing the centralized repository to redistribute prescription Page 1 of 21 CODING:
authorizing the department to facilitate the redistribution of donations of prescription drugs or Page 1 of 14 CODING:
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 drugs or supplies;
hb0059-03-c3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/CS/HB 59 2019 supplies;
authorizing a local repository to transfer prescription drugs or supplies to another local repository with authorization from the centralized repository;
authorizing a repository to transfer prescription drugs or supplies to another repository after notifying the department;
requiring a local repository to notify the department of its intent to participate in the program;
specifying patients eligible to receive donated prescription drugs and supplies;
providing notification requirements;
providing a procedure for a local repository to withdraw from participation in the program;
requiring the department to adopt rules regarding the disposition of prescription drugs and supplies of a withdrawing local repository;
requiring a local repository to issue an eligible patient who completes an intake collection form a program identification card;
requiring that such form provide certain notice to patients;
requiring the centralized repository to submit an annual report to the department;
requiring the department to establish, maintain, and publish a registry of participating repositories and available donated prescription drugs and supplies;
requiring the department or contractor to establish, maintain, and publish a registry of Page 2 of 21 CODING:
Words stricken are deletions;
words underlined are additions.
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 participating local repositories and available donated prescription drugs and supplies;
providing immunity from civil and criminal liability and from professional disciplinary action for participants under certain circumstances;
providing immunity from civil and criminal liability and from professional disciplinary action for donors and participants under certain circumstances;
providing immunity to pharmaceutical manufacturers, under certain circumstances, from any claim or injury arising from the donation of any prescription drug or supply under the program;
providing immunity to pharmaceutical manufacturers, under certain circumstances, from any claim or injury arising from the donation of any prescription drug or Page 2 of 14 CODING:
requiring dispensers to provide certain notice to patients;
authorizing the department to establish a direct-support organization to provide assistance, funding, and promotional support for program activities;
providing organizational requirements for a direct-support organization;
specifying direct-support organization purposes and objectives;
prohibiting the direct- support organization from lobbying;
specifying that the direct-support organization is not a lobbying firm;
prohibiting the direct-support organization from possessing prescription drugs on behalf of the program;
providing limitations on expenditures of such direct-support organization;
specifying that the direct-support organization must operate under contract with the department;
specifying required Page 3 of 21 CODING:
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 contract terms;
hb0059-03-c3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/CS/HB 59 2019 supply under the program;
providing for the direct-support organization board of directors;
specifying the board's membership requirements;
Show all 291 changed rows (251 more)
Previous
Latest
specifying requirements and requiring the department to adopt rules relating to a direct-support organization's use of department property;
specifying requirements for the deposit and use of funds by the direct-support organization;
providing for annual audits of a direct- support organization;
providing for future legislative review and repeal of provisions relating to the direct-support organization;
93 Be It Enacted by the Legislature of the State of Florida:
Be It Enacted by the Legislature of the State of Florida:
95 Section 1.
Section 1.
Page 4 of 21 CODING:
(a) "Closed drug delivery system" means a system in which the actual control of the unit-dose medication package is maintained by the facility, rather than by the individual patient.
Words stricken are deletions;
(b) "Controlled substance" means any substance listed under Schedule II, Schedule III, Schedule IV, or Schedule V of s.
words underlined are additions.
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 (a) "Centralized repository" means a distributor permitted under chapter 499 who is approved by the department or the contractor to accept, inspect, inventory, and distribute donated drugs and supplies under this section.
(b) "Closed drug delivery system" means a system in which the actual control of the unit-dose medication package is maintained by the facility, rather than by the individual patient.
(c) "Contractor" means the third-party vendor approved by the department to implement and administer the program as authorized in subsection (4).
(d) "Controlled substance" means any substance listed under Schedule II, Schedule III, Schedule IV, or Schedule V of s.
(e) "Direct-support organization" means the entity created under subsection (15).
(c) "Dispenser" means a health care practitioner who, within the scope of his or her practice act, is authorized to dispense medicinal drugs and who does so under this act.
(f) "Dispenser" means a health care practitioner who, within the scope of his or her practice act, is authorized to dispense medicinal drugs and who does so under this act.
Page 3 of 14 CODING:
(g) "Donor" means an entity specified in subsection (5).
(h) "Eligible patient" means a Florida resident who is indigent, uninsured, or underinsured and who has a valid prescription for a prescription drug or supply that may be dispensed under the program.
(i) "Free clinic" means a clinic that delivers only Page 5 of 21 CODING:
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 medical diagnostic services or nonsurgical medical treatment free of charge to low-income recipients.
hb0059-03-c3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/CS/HB 59 2019 (d) "Free clinic" means a clinic that delivers only medical diagnostic services or nonsurgical medical treatment free of charge to low-income recipients.
(j) "Health care practitioner" or "practitioner" means a practitioner licensed under this chapter, chapter 458, chapter 459, chapter 461, chapter 463, chapter 464, or chapter 466.
(e) "Health care practitioner" or "practitioner" means a practitioner licensed under this chapter, chapter 458, chapter 459, chapter 461, chapter 463, chapter 464, or chapter 466.
(k) "Indigent" means an individual whose family income for the 12 months preceding the determination of income is below 200 percent of the federal poverty level as defined by the most recently revised poverty income guidelines published by the United States Department of Health and Human Services.
(f) "Indigent" means having a family income for the 12 months preceding the determination of income that is below 200 percent of the federal poverty level as defined by the most recently revised poverty income guidelines published by the United States Department of Health and Human Services.
(l) "Local repository" means a health care practitioner's office, a pharmacy, a hospital with a closed drug delivery system, a nursing home facility with a closed drug delivery system, or a free clinic or nonprofit health clinic that is licensed or permitted to dispense medicinal drugs in the state.
(g) "Nonprofit health clinic" means a nonprofit legal entity that provides medical care to patients who are indigent, uninsured, or underinsured.
(m) "Nonprofit health clinic" means a nonprofit legal entity that provides medical care to patients who are indigent, uninsured, or underinsured.
(n) "Nursing home facility" has the same meaning as in s.
(h) "Nursing home facility" has the same meaning as in s.
(o) "Prescriber" means a health care practitioner who, within the scope of his or her practice act, is authorized to Page 6 of 21 CODING:
(i) "Prescriber" means a health care practitioner who, within the scope of his or her practice act, is authorized to prescribe medicinal drugs.
(j) "Prescription drug" has the same meaning as the term "medicinal drugs" or "drugs," as those terms are defined in s.
465.003(8), but does not include controlled substances, cancer Page 4 of 14 CODING:
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 prescribe medicinal drugs.
hb0059-03-c3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/CS/HB 59 2019 drugs donated under s.
(p) "Prescription drug" has the same meaning as the term "medicinal drugs" or "drugs," as those terms are defined in s.
499.029, or drugs with an approved Federal Food and Drug Administration risk evaluation and mitigation strategy that includes elements to assure safe use.
465.003(8), but does not include controlled substances or cancer drugs donated under s.
(k) "Program" means the Prescription Drug Donation Repository Program created by this section.
499.029.
(l) "Supply" means a material or an instrument used to administer a prescription drug.
(q) "Program" means the Prescription Drug Donation Repository Program created by this section.
(m) "Tamper-evident packaging" means a package that has one or more indicators or barriers to access which, if breached or missing, can reasonably be expected to provide visible evidence to consumers that tampering has occurred.
(r) "Supplies" means any supply used in the administration of a prescription drug.
The term includes, but is not limited to, unopened unit-dose packaging, multiple-dose packaging, and medications with a seal on their immediate, outer, secondary, or tertiary packaging.
(s) "Tamper-evident packaging" means a package that has one or more indicators or barriers to entry which, if breached or missing, can reasonably be expected to provide visible evidence to consumers that tampering has occurred.
(n) "Underinsured" means having health care coverage or prescription drug coverage, but having exhausted these benefits or not having prescription drug coverage for the drug prescribed.
(t) "Underinsured" means a person who has third-party insurance or is eligible to receive prescription drugs or supplies through the Medicaid program or any other prescription drug program funded in whole or in part by the Federal Government, but who has exhausted these benefits or does not have prescription drug coverage for the drug prescribed.
(o) "Uninsured" means not having health care coverage and being ineligible for prescription drug coverage under a program funded in whole or in part by the Federal Government.
(u) "Uninsured" means a person who has no third-party insurance and is not eligible to receive prescription drugs or supplies through the Medicaid program or any other prescription drug program funded in whole or in part by the Federal Government.
Page 7 of 21 CODING:
CREATION;
PURPOSE.—The Prescription Drug Donation Repository Program is created within the department to facilitate the donation of prescription drugs and supplies to eligible Page 5 of 14 CODING:
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 CREATION;
hb0059-03-c3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/CS/HB 59 2019 patients.
PURPOSE.—The Prescription Drug Donation Repository Program is created within the department for the purpose of authorizing and facilitating the donation of prescription drugs and supplies to eligible patients.
(4) REPOSITORIES.— (a) A repository may accept and dispense eligible donations to eligible patients under the program.
(4) PROGRAM IMPLEMENTATION;
The repository must inspect, store, and dispense donations and report to the department in accordance with this section.
ADMINISTRATION.—The department may contract with a third-party vendor to administer the program.
(b) The following entities may participate as a repository:
(5) DONOR ELIGIBILITY.—The centralized repository or a local repository may accept a donation of a prescription drug or supply only from:
1.
A health care practitioner's office.
2.
A pharmacy.
3.
A hospital with a closed drug delivery system.
4.
A nursing home facility with a closed drug delivery system.
5.
A free clinic or nonprofit health clinic that is licensed or permitted to dispense medicinal drugs in the state.
(c) An eligible entity must notify the department of its intent to participate in the program as a repository before accepting or dispensing any donations under the program.
The notification must be made on a physical or an electronic form prescribed by the department in rule and must, at a minimum, include:
1.
The name, street address, website, and telephone number of the intended repository and any license or registration number issued by the state to the intended repository, including the name of the issuing agency.
Page 6 of 14 CODING:
Words stricken are deletions;
words underlined are additions.
hb0059-03-c3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/CS/HB 59 2019 2.
The name and telephone number of the pharmacist employed by or under contract with the intended repository who is responsible for the inspection of donated prescription drugs and supplies.
3.
A signed and dated statement by the responsible pharmacist affirming that the intended repository meets the eligibility requirements of this subsection.
(d) A repository may withdraw from participation in the program at any time by providing written notice to the department, as appropriate, on a physical or an electronic form prescribed by the department in rule.
The department shall adopt rules addressing the disposition of prescription drugs and supplies in the possession of the withdrawing repository.
(5) ELIGIBLE DONORS.—The following entities may donate prescription drugs or supplies to a repository under the program:
(g) Prescribers who receive prescription drugs or supplies directly from a drug manufacturer, wholesale distributor, or pharmacy.
(g) Prescribers who receive prescription drugs or supplies Page 7 of 14 CODING:
(6) PRESCRIPTION DRUGS AND SUPPLIES ELIGIBLE FOR DONATION;
DONATION REQUIREMENTS;
PROHIBITED DONATIONS.— (a) Only prescription drugs and supplies that have been approved for medical use in the United States and that meet the Page 8 of 21 CODING:
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 criteria for donation established by this section may be accepted for donation under the program.
hb0059-03-c3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/CS/HB 59 2019 directly from a drug manufacturer, wholesale distributor, or pharmacy.
Donations must be made on the premises of the centralized repository or a local repository to a person designated by the repository.
(6) ELIGIBLE DONATIONS;
A drop box may not be used to accept donations.
DONATION REQUIREMENTS;
(b) The centralized repository or a local repository may accept a prescription drug only if:
PROHIBITED DONATIONS.— (a) An eligible donor may only donate a prescription drug to a repository if:
The drug is in its original sealed and tamper-evident packaging.
The drug is approved for medical use in the United States.
Single-unit-dose drugs may be accepted if the single- unit-dose packaging is unopened.
The drug requires storage at normal room temperature per the manufacturer or the United States Pharmacopeia.
The drug is in unopened, tamper-evident packaging.
The drug has been stored according to manufacturer or United States Pharmacopeia storage requirements.
The drug requires storage at normal room temperature per the manufacturer or federal storage requirements.
The drug does not have any physical signs of tampering or adulteration and there is no reason to believe that the drug is adulterated.
The drug has been stored according to manufacturer or federal storage requirements.
The packaging does not have any physical signs of tampering, misbranding, deterioration, compromised integrity, or adulteration.
The drug does not have any physical signs of tampering or adulteration and there is no reason to believe that the drug is adulterated.
The packaging indicates the lot number and expiration date of the drug.
The packaging does not have any physical signs of tampering, misbranding, deterioration, compromised integrity, or adulteration.
If the lot number is not retrievable, all specified medications must be destroyed in the event of a recall.
The drug has an expiration date that is more than 3 Page 9 of 21 CODING:
The packaging indicates the expiration date of the drug.
If the lot number is not retrievable, all specified medications must be destroyed in the event of a recall.
8.
The drug has an expiration date that is more than 3 months after the date on which the drug was donated.
(b) An eligible donor may donate a prescription drug or Page 8 of 14 CODING:
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 months after the date that the drug was donated.
hb0059-03-c3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/CS/HB 59 2019 supply to a repository only if it is in unopened, tamper-evident packaging.
(c) The centralized repository or a local repository may accept supplies only if they are in their original, unopened, sealed packaging and have not been tampered with or misbranded.
(c) Donations must be made on the premises of a repository to a person designated by the repository.
(d) Prescription drugs or supplies may not be donated to a specific patient.
A drop box may not be used to accept donations.
(e) Prescription drugs billed to and paid for by Medicaid in long-term care facilities which are eligible for return to stock under federal Medicaid regulations must be credited to Medicaid and may not be donated under the program.
(d) A prescription drug or supply may not be donated to a specific patient.
(f) Prescription drugs with an approved Federal Food and Drug Administration Risk Evaluation and Mitigation Strategy that includes Elements to Assure Safe Use are not eligible for donation under the program.
(7) INSPECTION AND STORAGE.— (a) Upon receipt of a proposed donation, a licensed pharmacist employed by or under contract with a repository shall inspect the donation to determine whether it meets the requirements of subsections (5) and (6).
(g) This section does not require the centralized repository or a local repository to accept a donation of prescription drugs or supplies.
The repository shall quarantine a donation until such inspection is complete and the donation is approved for dispensing.
(7) INSPECTION AND STORAGE.— (a) A licensed pharmacist employed by or under contract with the centralized repository or a local repository shall inspect donated prescription drugs and supplies to determine whether they meet the requirements of subsections (5) and (6).
(b) The inspecting pharmacist must sign an inspection record on a physical or an electronic form prescribed by the department in rule which verifies that the prescription drug or supply meets the criteria of subsections (5) and (6) and must attach the record to the inventory required by paragraph (d).
(b) The inspecting pharmacist must sign an inspection record on a form prescribed by the department by rule which verifies that the prescription drugs and supplies meet the Page 10 of 21 CODING:
A repository that receives prescription drugs and supplies from another repository is not required to reinspect such drugs and supplies.
(c) A repository shall store donations in a secure storage area under the environmental conditions specified by the manufacturer or federal storage requirements.
Donations may not Page 9 of 14 CODING:
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 criteria of subsections (5) and (6) and must attach the record to the inventory required by paragraph (d).
hb0059-03-c3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/CS/HB 59 2019 be stored with other inventory.
A local repository that receives drugs and supplies from the centralized repository is not required to reinspect them.
(d) A repository shall maintain an inventory of the name, strength, available quantity, and expiration date of donations;
(c) The centralized repository and local repositories shall store donated prescription drugs and supplies in a secure storage area under the environmental conditions specified by the manufacturer or the United States Pharmacopeia for the respective prescription drugs or supplies.
the transaction date;
Donated prescription drugs and supplies may not be stored with other inventory.
and the name, street address, and telephone number of the donor.
A local repository shall quarantine donated prescription drugs or supplies until they are inspected and approved for dispensing under this section.
The repository shall record such inventory on a physical or an electronic form prescribed by the department in rule.
(d) The centralized repository and local repositories shall maintain an inventory of all donated prescription drugs or supplies.
(e) By the 5th day of each month, a repository shall submit to the department its inventory records of donations received during the previous month.
Such inventory at local repositories shall be recorded on a form prescribed by the department by rule.
(f) The department may facilitate the redistribution of donations between repositories.
(e) A local repository shall notify the centralized repository within 5 days after receipt of any donation of prescription drugs or supplies to the program.
A repository that receives donations may, after notifying the department, distribute the donations to another repository.
The notification must be on a form prescribed by the department by rule.
(8) ELIGIBLE PATIENTS;
(f) The centralized repository may redistribute prescription drugs and supplies by transferring them to or from the centralized repository and a local repository, as needed.
DISPENSING REQUIREMENTS;
A local repository that receives donated prescription drugs or Page 11 of 21 CODING:
PATIENT NOTICE;
Words stricken are deletions;
PROHIBITIONS.— (a) A repository may dispense an eligible donation to a state resident who is indigent, uninsured, or underinsured, and who has a valid prescription for such donation, as applicable.
words underlined are additions.
(b) Each new eligible patient must submit an intake collection form to a repository to receive a donation using a physical or an electronic form prescribed by the department in rule.
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 supplies may, with authorization from the centralized repository, distribute the prescription drugs or supplies to another local repository.
Such form shall, at a minimum, include:
(8) PROGRAM PARTICIPATION.— (a) A practitioner, pharmacy, facility, or clinic must notify the department of its intent to participate in the program as a local repository before accepting or dispensing any prescription drugs or supplies pursuant to this section.
The notification must be made on a form prescribed by the department by rule and must, at a minimum, include:
The name, street address, website, and telephone number of the intended local repository and any license or registration number issued by the state to the intended local repository, including the name of the issuing agency.
The name, street address, and telephone number of the eligible patient.
2.
Page 10 of 14 CODING:
The name and telephone number of the pharmacist employed by or under contract with the intended local repository who is responsible for the inspection of donated prescription drugs and supplies.
3.
A signed and dated statement by the responsible pharmacist affirming that the intended local repository meets the eligibility requirements of this section.
(b) A local repository may withdraw from participation in the program at any time by providing written notice to the department or contractor, as appropriate, on a form prescribed by the department by rule.
The department shall adopt rules Page 12 of 21 CODING:
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 addressing the disposition of prescription drugs and supplies in the possession of the withdrawing local repository.
hb0059-03-c3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/CS/HB 59 2019 2.
(9) DISPENSING REQUIREMENTS;
The basis for the patient's eligibility, which must specify that the patient is indigent, uninsured, or underinsured.
PROHIBITIONS.— (a) Each eligible patient without a program identification card must submit an intake collection form to a local repository before receiving prescription drugs or supplies under the program.
The department shall prescribe a form by rule, which must include at least all of the following:
1.
The name, street address, and telephone number of the eligible patient.
2.
The basis for eligibility, which must specify that the patient is indigent, uninsured, or underinsured.
A statement signed and dated by the eligible patient affirming that he or she meets the eligibility requirements of this section.
A statement physically or electronically signed and dated by the patient affirming that the patient meets the eligibility requirements of this section and will inform the repository if the patient's eligibility changes.
(b) Upon receipt of a completed and signed intake collection form, the local repository shall issue him or her a program identification card, which is valid for 1 year after its date of issuance.
4.
The card must be in a form prescribed by the department by rule.
Notice that the prescription drug or supply was donated to the program, that the donors and participants in the program are immune from civil or criminal liability or disciplinary action, and that the eligible patient is not required to pay for the prescription drug or supply.
(c) The local repository shall send a summary of each intake collection form to the centralized pharmacy within 5 days after receiving it.
5.
(d) A dispenser may dispense donated prescription drugs or supplies only to an eligible patient who has a program Page 13 of 21 CODING:
A statement physically or electronically signed and dated by the eligible patient acknowledging receipt of notice required under this paragraph.
(c) By the 5th day of each month, a repository shall submit to the department a summary of each intake collection form obtained during the previous month.
(d) A dispenser may dispense donations, if available, only to an eligible patient who has submitted a completed intake collection form.
(e) A dispenser may provide dispensing and consulting services to an eligible patient.
(f) Donations may not be sold or resold.
(g) A dispenser may not submit a claim or otherwise seek Page 11 of 14 CODING:
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 identification card or who has submitted a completed intake collection form.
hb0059-03-c3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/CS/HB 59 2019 reimbursement from any public or private third-party payor for donations.
(e) A dispenser shall inspect the donated prescription drugs or supplies before dispensing them.
(9) RECALLED PRESCRIPTION DRUGS.— (a) Each repository shall establish and follow a protocol for notifying recipients in the event that a prescription drug donated under the program is recalled.
(f) A dispenser may provide dispensing and consulting services to an eligible patient.
(b) A repository shall destroy all donated prescription drugs that are recalled, expired, or unsuitable for dispensing.
(g) Donated prescription drugs and supplies may not be sold or resold under the program.
A repository must complete a destruction form for all such drugs using a physical or an electronic form prescribed by the department in rule.
(h) A dispenser of donated prescription drugs or supplies may not submit a claim or otherwise seek reimbursement from any public or private third-party payor for donated prescription drugs or supplies dispensed under this program.
(10) RECORDKEEPING.— (a) A repository shall maintain records of prescription drugs and supplies that are accepted, donated, dispensed, distributed, or destroyed under the program using a physical or an electronic form prescribed by the department in rule.
(10) RECALLED PRESCRIPTION DRUGS AND SUPPLIES.— (a) The centralized repository and each local repository shall establish and follow a protocol for notifying recipients in the event of a prescription drug recall.
(b) All required records must be maintained in accordance with any applicable practice act.
(b) Local repositories shall destroy all recalled or expired prescription drugs and all prescription drugs that are not suitable for dispensing in the repository.
A repository shall submit these records monthly to the department for data collection.
Local repositories must complete a destruction information form for all such drugs, in accordance with department rule.
(11) REGISTRIES;
(11) RECORDKEEPING.— (a) Local repositories shall maintain records of prescription drugs and supplies that are accepted, donated, dispensed, distributed, or destroyed under the program.
PUBLICATION OF FORMS.— (a) The department shall establish and maintain registries of all repositories and of prescription drugs and supplies available under the program.
Page 14 of 21 CODING:
The registry of repositories must include each repository's name, street address, website, and telephone number.
The registry of available prescription drugs Page 12 of 14 CODING:
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 (b) All required records must be maintained in accordance with any applicable practice act.
hb0059-03-c3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/CS/HB 59 2019 and supplies must include the name, strength, available quantity, and expiration date of the prescription drugs or supplies and the name and contact information of each repository where such drugs or supplies are available.
Local repositories shall submit these records quarterly to the centralized repository for data collection, and the centralized repository shall submit these records and the collected data in annual reports to the department.
(12) REGISTRIES;
PUBLICATION OF FORMS.— (a) The department or contractor shall establish and maintain registries of all local repositories and of prescription drugs and supplies available under the program.
The registry of local repositories must include each repository's name, address, website, and telephone number.
The registry of available prescription drugs and supplies must include the name, strength, available quantity, and expiration date of the prescription drug or supplies and the name and contact information of each repository where such drug or supplies are available.
(13) IMMUNITY FROM LIABILITY, DISCIPLINARY ACTION.— (a) Any donor of prescription drugs or supplies and any participant in the program who exercises reasonable care in donating, accepting, distributing, or dispensing prescription drugs or supplies under the program is immune from civil or Page 15 of 21 CODING:
(12) IMMUNITY FROM LIABILITY;
DISCIPLINARY ACTION.— (a) Any donor of prescription drugs or supplies and any participant in the program who exercises reasonable care in donating, accepting, distributing, or dispensing prescription drugs or supplies under the program is immune from civil or criminal liability and from professional disciplinary action by the state for any injury, death, or loss to person or property relating to such activities.
(b) A pharmaceutical manufacturer who exercises reasonable care is not liable for any claim or injury arising from the donation of any prescription drug or supply under this section, including, but not limited to, liability for failure to transfer or communicate product or consumer information regarding the donated prescription drug or supply, including its expiration date.
(13) RULEMAKING.—The department shall adopt rules necessary to administer this section.
Section 2.
Paragraph (o) is added to subsection (5) of Page 13 of 14 CODING:
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 criminal liability and from professional disciplinary action by the state for any injury, death, or loss to person or property relating to such activities.
hb0059-03-c3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/CS/HB 59 2019 section 252.36, Florida Statutes, to read:
(b) A pharmaceutical manufacturer who exercises reasonable care is not liable for any claim or injury arising from the donation of any prescription drug or supply under this section, including, but not limited to, liability for failure to transfer or communicate product or consumer information regarding the donated prescription drug, including its expiration date.
(14) NOTICE TO PATIENTS.—Before dispensing a donated prescription drug under the program, the dispenser must provide written notification to the eligible patient or his or her legal representative, receipt of which must be acknowledged in writing, of all of the following information:
(a) The prescription drug was donated to the program.
(b) The donors and participants in the program are immune from civil or criminal liability or disciplinary action.
(c) The eligible patient is not required to pay for the prescription drug.
(15) DIRECT-SUPPORT ORGANIZATION.—The department may establish a direct-support organization to provide assistance, funding, and promotional support for the activities authorized under the act.
(a) Entity organization.—The direct-support organization must operate in accordance with s.
20.058 and is:
Page 16 of 21 CODING:
Words stricken are deletions;
words underlined are additions.
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 1.
A Florida corporation not for profit incorporated under chapter 617, exempted from filing fees, and approved by the Department of State.
2.
Organized and operated to conduct programs and activities;
raise funds and request and receive grants, gifts, and bequests of moneys;
acquire, receive, hold, and invest, in its own name, securities, funds, objects of value, or other property, either real or personal;
and make expenditures or provide funding to or for the direct or indirect benefit of the program.
(b) Purposes and objectives.—The purposes and objectives of the direct-support organization must be consistent with the goals of the department, in the best interest of the state, and in accordance with the adopted goals and the mission of the department.
(c) Prohibition against lobbying.—The direct-support organization is not considered a lobbying firm, as that term is defined in s.
11.045(1).
All expenditures of the direct-support organization must be directly related to program administration within the requirements of this section.
Funds of the direct- support organization may not be used for the purpose of lobbying, as that term is defined in s.
11.045(1).
(d) Possession of prescription drugs.—The direct-support organization may not possess any prescription drugs on behalf of the program.
Page 17 of 21 CODING:
Words stricken are deletions;
words underlined are additions.
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 (e) Contract.—The direct-support organization shall operate under a written contract with the department.
1.
The contract must require the direct-support organization to submit to the department, annually by August 1, the following information, which must be posted on the websites of the direct-support organization and the department:
a.
The articles of incorporation and bylaws of the direct- support organization, as approved by the department.
b.
A proposed annual budget for the approval of the department.
c.
The code of ethics of the direct-support organization.
d.
The statutory authority or executive order that created the direct-support organization.
e.
A brief description of the direct-support organization's mission and any results obtained by the direct- support organization.
f.
A brief description of the direct-support organization's annual plan for each of the next 3 fiscal years.
g.
A copy of the direct-support organization's most recent federal Internal Revenue Service Return Organization Exempt from Income Tax form (Form 990).
h.
Certification by the department that the direct-support organization is complying with the terms of the contract and operating in a manner consistent with the goals and purposes of the department and the best interest of the program and the Page 18 of 21 CODING:
Words stricken are deletions;
words underlined are additions.
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 state.
Such certification must be made annually and reported in the official minutes of a meeting of the board of directors of the direct-support organization.
2.
The contract must, at a minimum, provide for:
a.
The reversion without penalty to the department, or to the state if the department ceases to exist, of all moneys and property held in trust by the direct-support organization for the benefit of the program if the direct-support organization ceases to exist or if the contract is terminated.
b.
A disclosure of material provisions of the contract and the distinction between the department and the direct-support organization to appear on all promotional and fundraising publications.
c.
A list of prescription drugs solicited by the direct- support organization for distribution to the centralized repository or a local repository.
(f) Board of directors.—The State Surgeon General shall appoint the board of directors, which must consist of at least 5 members, but not more than 15 members, who serve at his or her pleasure.
The board must elect a chair from among its members.
Board members must serve without compensation but may be entitled to reimbursement of travel and per diem expenses in accordance with s.
112.061, if funds are available for this purpose.
(g) Use of property.—The department may allow, without Page 19 of 21 CODING:
Words stricken are deletions;
words underlined are additions.
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 charge, appropriate use of fixed property, facilities, and personnel services of the department by the direct-support organization for purposes related to the program.
For purposes of this paragraph, the term "personnel services" includes full- time or part-time personnel, as well as payroll processing services.
1.
The department may prescribe any condition with which the direct-support organization must comply in order to use fixed property or facilities of the department.
2.
The department may not allow the use of any fixed property or facilities of the department by the direct-support organization if the organization does not provide equal membership and employment opportunities to all persons regardless of race, color, religion, sex, age, or national origin.
3.
The department shall adopt rules prescribing the procedures by which the direct-support organization is governed and any conditions with which a direct-support organization must comply to use property or facilities of the department.
(h) Deposit of funds.—Any moneys of the direct-support organization may be held in a separate depository account in the name of the organization and subject to the provisions of the organization's contract with the department.
(i) Use of funds.—Funds designated for the direct-support organization must be used for the enhancement of program Page 20 of 21 CODING:
Words stricken are deletions;
words underlined are additions.
hb0059-02-c2 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/CS/HB 59 2019 projects and in a manner consistent with that purpose.
Any administrative costs of running and promoting the purposes of the organization or program must be paid by private funds.
(j) Audit.—The direct-support organization shall provide for an annual financial audit in accordance with s.
215.981.
(k) Repeal.—This subsection is repealed on October 1, 2024, unless reviewed and saved from repeal by the Legislature.
(16) RULEMAKING.—The department shall adopt rules necessary to administer this section.
When applicable, the rules may provide for the use of electronic forms, recordkeeping, and meeting by teleconference.
Section 2.
Paragraph (o) is added to subsection (5) of section 252.36, Florida Statutes, to read:
Page 21 of 21 CODING:
Page 14 of 14 CODING:
hb0059-02-c2
hb0059-03-c3
View plain text versions (4)

Action History

  1. Died in Health Policy

  2. Indefinitely postponed and withdrawn from consideration

  3. Received

  4. Referred to Health Policy; Appropriations

  5. In Messages

  6. CS passed; YEAS 114 NAYS 0

  7. Read 3rd time

  8. Read 2nd time

  9. CS/CS/CS by Health and Human Services Committee read 1st time

  10. Placed on Special Order Calendar, 04/17/19

  11. Placed on Calendar

  12. Pending review of CS -under Rule 7.18(c)

  13. CS/CS/CS by- Health and Human Services Committee; YEAS 18 NAYS 0

  14. On Committee agenda-- Health and Human Services Committee, 04/09/19, 2:00 pm, Morris Hall

  15. CS/CS by Health Care Appropriations Subcommittee read 1st time

  16. Now in Health and Human Services Committee

  17. Pending review of CS under Rule 7.18(c)

  18. CS/CS by Health Care Appropriations Subcommittee; YEAS 9 NAYS 0

  19. On Committee agenda-- Health Care Appropriations Subcommittee, 04/02/19, 1:00 pm, Sumner Hall

  20. CS by Health Quality Subcommittee read 1st time

  21. Introduced

  22. Now in Health Care Appropriations Subcommittee

  23. Pending review of CS under Rule 7.18(c)

  24. CS by Health Quality Subcommittee; YEAS 15 NAYS 0

  25. On Committee agenda-- Health Quality Subcommittee, 02/20/19, 4:00 pm, Mashburn Hall

  26. Referred to Health Quality Subcommittee; Health Care Appropriations Subcommittee; Health and Human Services Committee

  27. Filed

Sponsors

  • Health Quality Subcommittee · Primary

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 163 not signed on

Sponsors (1)

  • Health Quality Subcommittee

Co-sponsors (0)

None.

Not signed on (163)

163 members have not signed on to this bill.

Show all 163 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Passage, Third Reading

Passed 114 Yea · 0 Nay · 6 Other
Party YeaNayPresentNot Voting
Democrat 11000
Unaffiliated 80001
Republican 23002
Total 114003
% of votes cast 97%0%0%3%
How each member voted (117)
Member Party Vote
Ausley — Yea
Brown — Yea
Byrd — Yea
Cummings — Yea
Diamond — Yea
Donalds — Yea
DuBose — Yea
Drake — Yea
Duran — Yea
Eagle — Yea
Fine — Yea
Fischer — Yea
Geller — Yea
Good — Yea
Hill — Yea
Ingoglia — Yea
Jacobs — Yea
Jacquet — Yea
Jenne — Yea
Killebrew — Yea
Magar — Yea
Mariano — Yea
McGhee — Yea
Mercado — Yea
Newton — Yea
Oliva — Yea
Payne — Yea
Pigman — Yea
Ponder — Yea
Pritchett — Yea
Renner — Yea
Rommel — Yea
Roth — Yea
Santiago — Yea
Silvers — Yea
Sprowls — Yea
Stevenson — Yea
Stone — Yea
Toledo — Yea
Tomkow — Yea
Willhite — Yea
Williamson — Yea
Roach — Yea
Grieco — Yea
Robinson — Yea
Bell — Yea
Hage — Yea
Rodrigues, R. — Yea
Beltran — Yea
Hart — Yea
Hattersley — Yea
Sabatini — Yea
Bush — Yea
Caruso — Yea
Casello — Yea
Clemons — Yea
Cortes — Yea
Latvala — Yea
Sullivan — Yea
Alexander — Yea
Aloupis — Yea
Altman — Yea
Grant, J. — Yea
Raschein — Yea
Grant, M. — Yea
Valdes — Yea
Fernandez — Yea
Omphroy — Yea
Watson, B. — Yea
Fernandez-Barquin — Yea
Watson, C. — Yea
Fetterhoff — Yea
Webb — Yea
Williams — Yea
Fitzenhagen — Yea
Goff-Marcil — Yea
Polo — Yea
Zika — Yea
Slosberg — Not Voting
La Rosa — Yea
Thompson, Geraldine F. "Geri" — Yea
Antone, Bruce Hadley Democrat Yea
Daniels, Kimberly Democrat Yea
Davis, Tracie Democrat Yea
Driskell, Fentrice Democrat Yea
Eskamani, Dr. Anna V. Democrat Yea
Gottlieb, Michael "Mike" Democrat Yea
Gregory, Emily Democrat Yea
Jones, Shevrin D. "Shev" Democrat Yea
Joseph, Dotie Democrat Yea
Polsky, Tina Scott Democrat Yea
Smith, Carlos Guillermo Democrat Yea
Andrade, Robert Alexander "Alex" Republican Yea
Brannan III, Robert Charles "Chuck" Republican Yea
Buchanan, James Republican Yea
Burton, Colleen Republican Yea
DiCeglie, Nick Republican Yea
Duggan, Wyman Republican Yea
Grall, Erin Republican Yea
Johnson, Chad Republican Yea
LaMarca, Chip Republican Yea
Leek, Thomas J. "Tom" Republican Yea
Massullo, Ralph E., Jr. Republican Yea
McClain, Stan Republican Yea
McClure, Lawrence Republican Yea
Overdorf, Tobin Rogers "Toby" Republican Yea
Perez, Daniel Republican Yea
Plakon, Rachel Saunders Republican Yea
Plasencia, Susan Republican Yea
Rodriguez, Ana Maria Republican Yea
Rodriguez, Ana Maria Republican Yea
Sirois, Tyler I. Republican Yea
Smith, David Republican Yea
Stark, Paula A. Republican Yea
Trumbull, Jay Republican Not Voting
Vacant Republican Not Voting
Yarborough, Clay Republican Yea

Official roll call →

Passed 18 Yea · 0 Nay
Party YeaNayPresentNot Voting
Unaffiliated 12000
Republican 5000
Democrat 1000
Total 18000
% of votes cast 100%0%0%0%
How each member voted (18)
Member Party Vote
Brown — Yea
Duran — Yea
Magar — Yea
Pigman — Yea
Ponder — Yea
Stevenson — Yea
Cortes, J. — Yea
Goff-Marcil — Yea
Grant, M. — Yea
Roach — Yea
Rodrigues, R. — Yea
Slosberg — Yea
Jones, Shevrin D. "Shev" Democrat Yea
Burton, Colleen Republican Yea
DiCeglie, Nick Republican Yea
Leek, Thomas J. "Tom" Republican Yea
Plakon, Rachel Saunders Republican Yea
Yarborough, Clay Republican Yea

Official roll call →

Passed 9 Yea · 0 Nay · 3 Other
Party YeaNayPresentNot Voting
Unaffiliated 8001
Republican 1001
Democrat 0001
Total 9003
% of votes cast 75%0%0%25%
How each member voted (12)
Member Party Vote
Ausley — Yea
Duran — Yea
Magar — Yea
Pigman — Yea
Rommel — Yea
Toledo — Not Voting
Grant, J. — Yea
Grieco — Yea
Roach — Yea
Jones, Shevrin D. "Shev" Democrat Not Voting
Grall, Erin Republican Yea
Plasencia, Susan Republican Not Voting

Official roll call →

Passed 15 Yea · 0 Nay
Party YeaNayPresentNot Voting
Unaffiliated 6000
Republican 6000
Democrat 3000
Total 15000
% of votes cast 100%0%0%0%
How each member voted (15)
Member Party Vote
Brown — Yea
Byrd — Yea
Fine — Yea
Bell — Yea
Beltran — Yea
Sullivan — Yea
Daniels, Kimberly Democrat Yea
Davis, Tracie Democrat Yea
Smith, Carlos Guillermo Democrat Yea
Burton, Colleen Republican Yea
Plakon, Rachel Saunders Republican Yea
Plasencia, Susan Republican Yea
Rodriguez, Ana Maria Republican Yea
Stark, Paula A. Republican Yea
Yarborough, Clay Republican Yea

Official roll call →

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 59?
HB 59 is sponsored by Health Quality Subcommittee.
What is the current status of HB 59?
This bill died with 2019 Regular Session. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 59?
Track HB 59 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 59

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 59

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →